Primary Site >> Colorectal Cancer

Gene >> BMP1

  • 1988
  • 1996
  • 2008
  • 2010
  • 2011
  • 2012
  • 2014
  • 2015
  • 2018
Ref: Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
PMID: 3263479
Ref: Design and dosimetric characteristics of a high dose rate remotely afterloaded endocavitary applicator system.
PMID: 8600101
Ref: Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells.
PMID: 18414391
Ref: Somatic frameshift mutations of bone morphogenic protein receptor 2 gene in gastric and colorectal cancers with microsatellite instability.
PMID: 20955454
Ref: Genetic variation in the transforming growth factor-beta signaling pathway and survival after diagnosis with colon and rectal cancer.
PMID: 21365634
Ref: Genetic variation in bone morphogenetic protein and colon and rectal cancer.
PMID: 21387313
Ref: In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidance.
PMID: 24835072
Ref: Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
PMID: 25820997
Ref: A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.
PMID: 26072521
Ref: Thermoluminescence dosimetry of the dose received by scrotum and testes in radiotherapy of rectal cancer, compared to the point doses calculated by 3D-planning software.
PMID: 29472079